{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:32:26Z","timestamp":1793658746789,"version":"4.5.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Associazione Italiana contro il Cancro","award":["19036"],"award-info":[{"award-number":["19036"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["H2020"],"award-info":[{"award-number":["H2020"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.jcyt.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T09:06:09Z","timestamp":1513069569000},"page":"262-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7932-909X","authenticated-orcid":false,"given":"Josee","family":"Golay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Pedrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Capelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Gotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmaria","family":"Borleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Magri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Vailati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Passera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Farina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3739-7502","authenticated-orcid":false,"given":"Alessandro","family":"Rambaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-0892","authenticated-orcid":false,"given":"Martino","family":"Introna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2017.11.009_bib0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1046\/j.1537-2995.1991.31691306250.x","article-title":"Adverse reactions in patients transfused with cryopreserved marrow","volume":"31","author":"Stroncek","year":"1991","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0015","first-page":"699","article-title":"Microbial contamination of peripheral blood stem cell collections","volume":"17","author":"Attarian","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0020","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/sj.bmt.1705731","article-title":"Microbial contamination of hematopoietic progenitor cell products: clinical outcome","volume":"40","author":"Patah","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0025","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1080\/14653240701420427","article-title":"Microbial contamination of BM products before and after processing: a report of incidence and immediate adverse events in 257 grafts","volume":"9","author":"Vanneaux","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0030","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1111\/trf.12150","article-title":"Microbial contamination of hematopoietic progenitor and other regenerative cells used in transplantation and regenerative medicine","volume":"53","author":"Jacobs","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0035","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/sj.bmt.1705421","article-title":"What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria?","volume":"38","author":"Kelly","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12879-015-1306-0","article-title":"Rapid diagnosis of Propionibacterium acnes infection in patient with hyperpyrexia after hematopoietic stem cell transplantation by next-generation sequencing: a case report","volume":"16","author":"Ye","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.transci.2016.05.001","article-title":"Does microbial contamination influence the success of the hematopoietic cell transplantation outcomes?","volume":"55","author":"Dal","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0050","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1046\/j.1423-0410.1998.7420088.x","article-title":"Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course","volume":"74","author":"Schwella","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0055","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3324\/haematol.11132","article-title":"Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study","volume":"92","author":"Introna","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0060","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/j.bbmt.2017.07.005","article-title":"Phase II study of sequential infusion of DLI and cytokine induced killer cells for patients relapsed after alloHSCT","volume":"23","author":"Introna","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0065","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bbmt.2013.11.033","article-title":"Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients","volume":"20","author":"Introna","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0070","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/sj.bmt.1705798","article-title":"Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts","volume":"40","author":"Capelli","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0075","doi-asserted-by":"crossref","first-page":"786","DOI":"10.3109\/14653249.2011.563294","article-title":"Minimally manipulated whole human umbilical cord is a rich source of clinical-grade human mesenchymal stromal cells expanded in human platelet lysate","volume":"13","author":"Capelli","year":"2011","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0080","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1056\/NEJM200101183440303","article-title":"Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers","volume":"344","author":"Bensinger","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0085","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1016\/j.transproceed.2014.09.002","article-title":"Microbial contamination of peripheral blood and bone marrow hematopoietic cell products and environmental contamination in a stem cell bank: a single-center report","volume":"46","author":"Kozlowska-Skrzypczak","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1537-2995.2005.04178.x","article-title":"Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts","volume":"45","author":"Kamble","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(77)90635-3","article-title":"Anaphylaxis after gentamycin","volume":"2","author":"Hall","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0100","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1034\/j.1398-9995.2003.23710_5.x","article-title":"Gentamicin-induced anaphylaxis","volume":"58","author":"Schulze","year":"2003","journal-title":"Allergy"},{"key":"10.1016\/j.jcyt.2017.11.009_bib0105","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jfma.2013.10.002","article-title":"Update on new medicinal applications of gentamicin: evidence-based review","volume":"113","author":"Chen","year":"2014","journal-title":"J Formosan Med Assoc"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917307727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324917307727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T01:34:03Z","timestamp":1761442443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324917307727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1465324917307727"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.11.009","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of routine evaluation of sterility of cellular therapy products with or without extensive manipulation: Best practices and clinical significance","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}